Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shengmai yin
- Development stage
- Unknown
- Lead developer
- Beijing Tongren Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shengmai Yin is a classical traditional Chinese medicine (TCM) formula composed of three primary herbal ingredients: *Panax ginseng* (Ginseng), *Ophiopogon japonicus* (Ophiopogon root), and *Schisandra chinensis* (Schisandra fruit). Traditionally used to replenish Qi, nourish Yin, and astringe sweat, it is widely utilized in modern clinical practice for cardiovascular conditions such as chronic heart failure, coronary heart disease, and hypotension. The formula is also recognized for its neuroprotective properties, particularly in the context of ophthalmic diseases. It is believed to improve microcirculation, reduce oxidative stress, and inhibit apoptosis in retinal ganglion cells, which has led to its investigation as a potential treatment for normal tension glaucoma. Shengmai Yin is typically administered as an oral liquid, though other formulations like capsules and injections exist.
- Brand names
- Shengmai Yin
- Other names
- Shengmai SanShengmai FormulaSheng-Mai-SanSheng-Mai-Yin
02
Targets
CASP3 (Caspase-3)
Beyond the preview
Go deeper on shengmai yin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shengmai yin.